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Abstract
Objective:
The objective of this study was to assess long-term postoperative urinary incontinence (UI) symptoms and
quality of life (QOL) in patients after robotic-assisted sacrocolpopexy (RASC) with or without
concomitant midurethral sling (MUS).
Materials and Methods:
This is a cross-sectional survey of patients comparing long-term postoperative urinary symptoms and QOL
measurements in women who underwent RASC with or without MUS. We included all patients from 2011
to 2014 who had RASC with or without MUS. All patients had preoperative urodynamic testing (UDS).
Patients who demonstrated stress UI on UDS underwent MUS at the time of RASC. Urinary symptoms
and QOL were assessed through the validated Urinary Distress Inventory-6 (UDI-6) and Incontinence
Impact Questionnaire-7 (IIQ-7) patient questionnaires.
Results:
Sixty-eight patients met inclusion criteria, 46 patients completed follow-up questionnaires, and were
included in the final analysis. Average length of time to follow-up from surgery was 24 months (range: 6–
36 months). A statistically significant difference in UDI-6 scores between the two groups (RASC vs.
RASC + MUS) was observed. Median (25  and 75  percentiles) scores for UDI-6 were 22.92 (8.33 and
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32.29, respectively) for the RASC group and 4.17 (0 and 13.54, respectively) for the RASC + MUS group
(P = 0.0017). Median scores for IIQ-7 were 0 (0 and 29.73 for the 25  and 75  percentiles, respectively)
for the RASC group and 0 (0 and 0, respectively) for the RASC + MUS group (P = 0.1691).
Conclusion:
Patients who underwent RASC + MUS scored significantly lower on the UDI-6, indicating fewer urinary
distress symptoms. Although not statistically significant, patients in the RASC + MUS group had lower
IIQ-7 scores, indicating less negative impact on QOL, compared to the RASC-only group.
K       : Midurethral sling, robotic surgery, sacrocolpopexy, stress urinary incontinence
I           
Pelvic organ prolapse (POP) rarely occurs in isolation. Two-thirds of women with POP have coexisting
stress urinary incontinence (SUI).[1] Women without preoperative SUI have a 16%–51% chance of
developing postoperative de novo SUI after surgical correction of POP.[2] Nygaard et al. established that
77% of patients without concomitant anti-incontinence procedure at the time of colpopexy developed SUI
and 6.5% of those patients eventually underwent an anti-incontinence procedure.[3] Two previous studies
demonstrated a 23% rate of de novo SUI after laparoscopic sacrocolpopexy, and a varied rate of
subsequent anti-incontinence procedures ranging from 5% to 15%.[4,5]
A meta-analysis of randomized controlled trials comparing POP surgery with or without anti-incontinence
surgery showed that the number needed to treat (NNT) to prevent one woman from developing SUI was
two, three, and nine for patients who had co-existing SUI, occult SUI, and asymptomatic continent
women, respectively. With regard to asymptomatic continent women, the NNT to prevent one woman from
undergoing an anti-incontinence procedure was twenty. The only notable complication identified after
concomitant surgery was prolonged catheterization, with persistent obstructive voiding found in 2% of
patients.[6]
Large prospective trials have confirmed the benefit of an anti-incontinence procedure at the time of
prolapse repair. The optimal angioplasty versus primary stenting (OPUS) trial demonstrated statistically
lower rates of urinary incontinence (UI) in patients who received a midurethral sling (MUS) at the time of
prolapse repair through a vaginal route.[7] In the CARE trial, patients who received a concomitant Burch
urethropexy at the time of abdominal sacrocolpopexy had lower rates of SUI with long-term follow-up.
When compared to Burch urethropexy, patients who received a MUS were shown to have similar
continence rates, however they had better patient-centered outcomes.[8] MUS was also associated with
shorter operative time, shorter hospital stay, and lower rate of voiding dysfunction.[9] Recently, more data
have shown the benefits of MUS over other surgical treatments for SUI, including shorter operative time,
shorter hospital stay, and lower rates of de novo urge incontinence.[9,10,11,12,13,14]
There are clear benefits to minimally invasive surgery (MIS) as compared to an open abdominal technique,
such as decreased estimated blood loss, fewer intraoperative complications, shorter recovery time, and
decreased postoperative pain.[15] As a result, rates of laparoscopic and robotic MIS are on the rise.
Despite the increasing data on the benefits of MIS, there are no current studies evaluating the possible
benefits of concomitant MUS at the time of robotic-assisted sacrocolpopexy (RASC).
Women who suffer from occult SUI after surgical correction of POP may be dissatisfied postoperatively.
[16] It is unclear whether surgeons should consider having a discussion regarding a concomitant anti-
incontinence procedure at the time of RASC.
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The objective of this study was to compare symptoms and quality of life (QOL) in patients who have
undergone RASC with or without concomitant MUS based on validated patient questionnaires. Secondary
outcome measures include the subjective success of the procedure as well as the associated complications
from the surgery. We hypothesized that patients undergoing concomitant MUS would have fewer urinary
distress symptoms and an improved QOL.
M             M      
This is a cross-sectional survey of patients comparing long-term postoperative urinary symptoms in
women who underwent RASC with or without concomitant MUS. Institutional Review Board approval
was obtained (IRB # 14-582). A retrospective chart review was performed on all female patients over the
age of 18, who underwent a RASC between 2011 and 2014 at North Shore University Hospital of
Northwell Health System. All patients had urodynamic testing (UDS) as a component of routine
preoperative evaluation. In patients with advanced POP, a rectal swab was used to reduce the prolapse and
assess for urine leakage with cough or Valsalva. All patients who were diagnosed with SUI on UDS
underwent MUS at the time of RASC. Patients were excluded from the study if they were diagnosed with
SUI on UDS and declined concomitant MUS placement at the time of surgery. Demographic data, POP-
Quantification (POP-Q), and Q-tip test scores were recorded.
Patients were dichotomized into groups based on preoperative UDS findings. The first group of patients
were diagnosed with SUI on UDS and thus underwent RASC with concomitant MUS (RASC + MUS).
The second group consisted of patients who were not diagnosed with SUI on UDS, and as such underwent
RASC without a concomitant anti-incontinence procedure (RASC-only). All RASC procedures were
performed by a single surgeon (HW) with robotic assistance from the da Vinci Si-HD  (Intuitive Surgical,
Inc., Sunnyvale, CA, USA) at a single tertiary hospital. The type of sling was based on surgeon's and
patient's preference after preoperative evaluation and counseling.
Two standard and validated questionnaires, the Urinary Distress Inventory-6 (UDI-6) and Incontinence
Impact Questionnaire-7 (IIQ-7),[17,18] were administered by telephone or mail to all patients who met the
inclusion criteria. Questionnaires completed by telephone were administered by an obstetrics and
gynecology resident and a urogynecology fellow. The UDI-6 is a 6-item questionnaire that addresses
symptoms associated with lower urinary tract dysfunction such as urinary frequency and urgency, SUI,
difficulty in urinating, pain, and discomfort due to leakage. The IIQ-7 is a 7-item questionnaire that
focuses on QOL relating to UI. The UDI-6 and the IIQ-7 questionnaires were scored as described by the
original developer: if more than two items were missing, a total score was not calculated. Higher scores
indicate more symptom distress (UDI-6), or greater negative impact on daily life (IIQ-7).
This study added two QOL inquiries in addition to the UDI-6 and the IIQ-7 [Table 1]. The first question
asked the patient to subjectively rate her postoperative POP symptoms compared to her preoperative
symptoms. The second question consisted of two parts that attempted to identify any complications as a
result of the surgery, and if applicable, the severity of those complications.
Descriptive statistics (mean ± standard deviation, median, 25  and 75  percentiles for continuous
variables; frequencies and percentages for categorical variables) were calculated for the overall sample of
patients (n = 46) who completed the questionnaires. Fisher's exact test was used to compare all the
categorical variables and the Mann–Whitney test was used to compare all the continuous variables. P <
0.05 was considered statistically significant. All analyses were performed using SAS version 9.4 (SAS
Institute Inc., Cary, NC, USA).
R      
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Sixty-eight patients met the inclusion criteria, 67.6% (n = 46) of which completed the follow-up
questionnaires and were included in the final analysis. Of the 24 patients who did not complete the follow-
up questionnaires, 12 were from the RASC + MUS group and 12 were from the RASC-only group. The
median (25  and 75  percentiles) age, BMI, and parity of our patient population are 62.5 (59 and 69),
25.6 (23.7 and 28.0), and 3 (2 and 3), respectively. POP-Q stage was 28.3% (n = 13), 45.7% (n = 21), and
26.1% (n = 12) for stage 2, 3, and 4, respectively. Thirty-five patients (76.1%) had a supracervical
hysterectomy at the time of RASC. Thirteen patients (28.3%) had a prior hysterectomy. Thirty patients
were diagnosed with SUI on UDS, hence thirty patients were in the RASC + MUS group and 16 were in
the RASC group. Preoperative positive cough stress test scores were significantly different between RASC
+ MUS and RASC-only groups, P = 0.049 (12 vs. 2, respectively). There were no significant differences
between the above-mentioned groups with regard to the remainder of the demographic parameters,
including urethral hypermobility [Table 2]. In the RASC + MUS group, 27 (90%) patients received a
transobturator sling and three received a retropubic sling. The average follow-up time was 24 months, with
a range of 6–36 months.
A statistically significant difference in UDI-6 scores between the two groups (RASC vs. RASC + MUS)
was observed. Median (25  and 75  percentiles) scores for UDI-6 were 22.92 (8.33 and 32.29) for the
RASC group and 4.17 (0 and 13.54) for the RASC + MUS group (P = 0.0017), respectively. Median
scores for IIQ-7 were 0 (0 and 29.73 for the 25  and 75  percentiles, respectively) for the RASC group
and 0 (0 and 0, for the 25  and 75  percentiles, respectively) for the RASC + MUS group (P = 0.1691) [
Table 3]. There were no statistically significant differences between the two groups for the three additional
nonvalidated questions in reference to the success of the surgery (question 14) as well as complications
from the surgery (question 15), P < 0.7412 and P < 0.2227, respectively.
The most common complication noted in the final question on the questionnaire was related to pain. Five
patients noted intermittent lower abdominal pain, two of whom were in the RASC + MUS group and three
were in the RASC-only group. Two patients in the RASC-only group specifically noted incontinence as a
complication of surgery, neither of whom were diagnosed with detrusor overactivity on preoperative UDS.
A cystotomy occurred in two patients, of note both were in the RASC-only group and both had a prior
total vaginal hysterectomy. Three patients noted constipation, two of which were in the RASC + MUS
group.
D         
Similar studies comparing concomitant treatment of POP and SUI have been performed; however at this
time, no such study exists that has investigated RASC with or without MUS. Significant differences were
found in the composite UDI-6 scores between the two groups. Although not statistically significant,
patients in the RASC-only group had higher IIQ-7 scores, indicating more of a negative impact on QOL.
Although the two groups were not exactly equivalent, the findings of this study align with others that
advocate for concomitant anti-incontinence procedures at the time of prolapse surgery.[7,9]
Limitations of this study are inherent with all retrospective studies. We were limited by the lack of
preoperative UDI-6 and IIQ-7 results with which to compare the postoperative results. However, the
greatest limitation of this study is the attempt to compare and draw conclusions from two similar groups
with one crucial difference, the diagnosis of SUI. Sling type was determined by the surgeon in conjunction
with patients based on their symptoms and concerns regarding possible complications and as such was not
consistent throughout the RASC + MUS group. Another limitation is the lack of consistency with respect
to the sling type. In addition, there was a relatively small sample size. Sample size was limited due to
robotic surgery only becoming available to our department in 2011 and only one surgeon was performing
RASC in our division during the study time frame. A single surgeon may be viewed positively or
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negatively with respect to our findings. A single surgeon reduces possible confounders, such as variance in
proficiency or techniques, and ensures that all surgeries were performed in a similar manner. However, the
results of a single surgeon make our data less generalizable.
Placement of MUS at the time of RASC has been reported, with mixed results.[19,20] This is the first
study to specifically look at the QOL factors after RASC with or without MUS. The RASC + MUS
patients had significantly fewer SUI symptoms as well as significantly improved QOL. This could indicate
that the patients in the RASC-only group, who were not diagnosed with SUI on preoperative UDS, may
have benefited from a prophylactic MUS. It is interesting to note that patients who were not diagnosed
with SUI had similar rates of urethral hypermobility as those who were diagnosed with SUI.
A strength of this study is the long-term follow-up. Despite a 2-year long-term follow-up, it is notable that
none of the RASC-only patients returned for further surgical treatment of SUI despite being symptomatic.
According to the CARE trial, 6.5% of patients in the abdominal sacrocolpopexy group without
concomitant Burch colposuspension pursued surgical treatment for SUI.[3] This difference could be
attributed to the route of colpopexy (laparotomy vs. laparoscopic), the type of anti-incontinence procedure
(urethropexy vs. MUS), or surgical technique.
We were successful in retrieving a 67.6% response rate for our questionnaire. Although we had fewer
responses than desired, this is above the average response rate of 60% for similar surveys published in
medical journals.[21] In addition, this study focused on the subjective cure rates as well as on the QOL. In
a survey of urogynecology patients, nurses, and medical staff, they ranked subjective cure rates and QOL
as most important over several other factors.[22]
Previous studies noted that 6.3 MUS would have to be placed during vaginal prolapse surgery to prevent
one patient from returning to the operating room for an anti-incontinence procedure.[7] It has also been
shown that universally performing MUS at the time of ASC is more cost-effective than both preoperative
UDS to determine whether or not to perform MUS and ASC alone (with the potential for subsequent MUS
as needed for occult SUI).[23]
This study contributes to the literature by demonstrating the potential benefit of concomitant MUS at the
time of RASC. Based on this study alone, it should not be inferred that all patients undergoing RASC
should be recommended a concurrent MUS. Larger prospective trials are warranted. Future studies could
randomize sling placement in patients without symptoms or the diagnosis of SUI and determine the
improvement of QOL and urinary distress symptoms as well as the rates of adverse events in that
population.
C         
Surgical treatment strategies should be tailored to each individual. In this study, patients who underwent
combined RASC and MUS had significantly fewer urinary symptoms. The results of this study align with
the findings of the CARE and the OPUS trials and thus patients should be counseled appropriately about
the potential benefits of a concomitant anti-incontinence procedure, regardless of UDS diagnosis, at the
time of RASC.
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Post-operative quality of life questionnaires
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Table 3
Comparison of Urinary Distress Inventory-6 and Incontinence Impact Questionnaire-7 scores
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